Esaú João

MedicineImmunology and MicrobiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial”.

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet(2021)10.1016/s0140-6736(21)00314-7

N/A

5.5DataRank · unranked

162 citations

Sean S. Brummel, Lauren Ziemba, Lynda Stranix‐Chibanda, Katie McCarthy, Anne Coletti +39 more

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial

The Lancet HIV(2020)10.1016/s2352-3018(20)30038-2

N/A

1.7DataRank · unranked

46 citations

R. L. Morrison, David E. Shapiro, Nahida Chakhtoura, Maria Isabel S. Gouvea, Maria de Lourdes Benamor Teixeira +23 more

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00061-9

N/A

1.1DataRank · unranked

30 citations

Lauren Ziemba, Sean S. Brummel, Katie McCarthy, Anne Coletti, Chelsea Krotje +95 more

Effect of Maternal Immunization With 10-Valent Pneumococcus Conjugate Vaccine (PCV-10), 23-Valent Pneumococcus Polysaccharide Vaccine, or Placebo on the Immunogenicity of PCV-10 in Human Immunodeficiency Virus–Exposed Uninfected Infants: A Randomized Clinical Trial

Clinical Infectious Diseases(2022)10.1093/cid/ciac026

N/A

0.360DataRank · unranked

10 citations

S. M. Ward, Lauren Laimon, Stephen I. Pelton, Jennifer Canniff, Amanda Golner +16 more

Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE)

Clinical Infectious Diseases(2023)10.1093/cid/ciad107

N/A

0DataRank · unranked

8 citations

Carlos Malvestutto, Janet Lo, Kathleen V. Fitch, Carl J. Fichtenbaum, Judith A. Aberg +14 more

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.02260-19

N/A

0DataRank · unranked

11 citations

Jiajia Wang, Khadija Amin, David E. Shapiro, Alice Stek, Elizabeth Smith +42 more

Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum

Clinical Infectious Diseases(2024)10.1093/cid/ciae001

N/A

0DataRank · unranked

12 citations

Sean S. Brummel, Lauren Ziemba, Lameck Chinula, Katie McCarthy, Lee Fairlie +88 more

Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab537

N/A

0DataRank · unranked

38 citations

Janet Lo, Carlos Malvestutto, Kathleen V. Fitch, Markella V. Zanni, Carl J. Fichtenbaum +11 more

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term

PLoS ONE(2022)10.1371/journal.pone.0275254

N/A

0DataRank · unranked

2 citations

Ingrid A. Beck, Sheila Styrchak, Samantha Hardy, Jackson Wallner, Ross Milne +6 more

Sustained Virologic Suppression Reduces HIV-1 DNA Proviral Levels and HIV Antibodies in Perinatally HIV-Infected Children Followed from Birth

Viruses(2022)10.3390/v14112350

N/A

0DataRank · unranked

1 citations

Tara Kerin, Ruth Cortado, Maria de Lourdes Benamor Teixeira, Maria Isabel Fragoso da Silveira Fragoso da Silveira Gouvêa, Christianne Moreira +11 more